Expanding Uses of Microbiota Transplant

The Microbiota Therapeutics Program led by Dr. Alexander Khoruts has been the world leader in development and manufacturing of microbiota-based therapeutics over the past decade. Microbiota transplant therapy is effective in treating the serious infection c. difficile. Now, it has been shown to be safe for patients with acute myeloid leukemia—a type of blood cancer—and recipients of hematopoietic cell transplantation. Both groups suffer the combined effects of chemotherapy wiping out gut bacteria and a suppressed immune system, making them vulnerable to infection. Research to find appropriate doses for these patients continues. View full story